Use of Benzodiazepines during Pregnancy, Labour and Lactation, with Particular Reference to Pharmacokinetic Considerations

  title={Use of Benzodiazepines during Pregnancy, Labour and Lactation, with Particular Reference to Pharmacokinetic Considerations},
  author={Jussi H. Kanto},
  • J. Kanto
  • Published 1 May 1982
  • Medicine
  • Drugs
SummaryKnowledge of the pharmacokinetic properties of the benzodiazepines is playing an increasingly important role in their use during pregnancy, labour and lactation. All of the benzodiazepine derivatives are lipophilic, undissociated agents which readily penetrate membranes. Thus, they exhibit rapid placental transfer with significant fetal uptake of the drug.In the first trimester of pregnancy there is seldom a clear indication for the use of benzodiazepines. In late pregnancy and at… 
Maternal and Infant Pharmacokinetics of Psychotropic Medications During Pregnancy and Lactation
The current available evidence on the pharmacokinetics of anxiolytics, antidepressants, antipsychotics, mood stabilizers, and opioids in the pregnant woman, the fetus, and the lactating infant is summarized.
Benzodiazepine Intoxication in a Neonate by Maternal Use in Pregnancy
A floppy, drowsy and pulmonary impaired newborn delivered in the 36th week of gestation was reported about by a regular user of clorazepate, a long-acting benzodiazepine during pregnancy.
Diazepam and its metabolites in the mothers' and newborns' hair as a biomarker of prenatal exposure.
Diazepam and its metabolites determined in hair of newborns may serve as biomarkers of prenatal exposure to these drugs and confirm that these benzodiazepines permeate placental barrier.
Drug dosing during pregnancy—opportunities for physiologically based pharmacokinetic models
This review collates examples of drugs with known recommendations for dose adjustment during pregnancy and provides an example of the potential use of PBPK models in dose adjustment recommendation during pregnancy within the context of drug-drug interactions.
Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects
This narrative review is aimed at the description of drugs and drug classes for which licit maternal use in the predelivery period has been associated with neonatal non-teratogenic disorders, mainly for substances used illicitly for recreational purposes.
Maternal use of sedative drugs and its effects on pregnancy outcomes: a Finnish birth cohort study
Evaluating maternal use of sedative drugs before, during, and after pregnancy and the influence of use of these drugs on pregnancy outcomes found no adverse birth or pregnancy outcomes in the group using sedatives compared with the non-users.


Clinical Pharmacokinetics of Diazepam
Based on kinetic data, a single administration of diazepam at night should be adequate for hypnotic and anxiolytic effects in most patients and measurement of blood levels is unnecessary.
Passage of diazepam and desmethyldiazepam into breast milk.
It was shown that diazepam and its main and also active metabolite desmethyldiazepam passed into the milk, and their concentrations remained small as compared to plasma values.
Clinical Pharmacokinetics in Neonates
It is clearly emerging that drug disposition may vary greatly in the newborn in relation to its developmental age, and the significance of various factors on drug dispostion during development will be better clarified, thus allowing a more rational and safer therapy inThe newborn.
Pharmacokinetics of the placental transfer and distribution of clorazepate and its metabolite nordiazepam in the feto-placental unit and in the neonate
Clorazepate 20mg was given to 49 mothers during the first stage of labour and the elimination of the drug was studied in 27 newborns produced by these mothers, finding that nordiazepam was found in the milk and in the blood of neonates after breast-feeding had started.
Diazepam in Labour: Its Metabolism and Effect on the Clinical Condition and Thermogenesis of the Newborn
Following the administration of diazepam to mothers in labour the clinical effects, changes in thermogenesis, and metabolism of the drug in the newborn were observed under carefully controlled
The disposition kinetics of diazepam in pregnant women at parturition
It is suggested that delivery alters the disposition of diazepam and is generally associated with a postnatal re-distribution ofdiazepam into the systemic circulation.
A study of the plasma concentrations of lorazepam in mother and neonate.
Measurements after delivery indicated that the neonates were able to metabolize lorazepam at the same rate as the mothers, and they had a lower Apgar score than the mothers.
Diazepam in Early Human Pregnancy
The concentrations of diazepam and N‐demethyl‐diazepam in fetal tissues are at a level comparable to the concentration ofDiazepam that has a damaging effect on cells in cellular cultures and this could constitute indirect evidence of metabolism in the fetal liver.
Transfer of free and conjugated oxazepam across the human placenta
Both in early and late pregnancy, the free and glucuronide conjugate of oxazepam were found in the fetus at concentrations which indicated transplacental passage of the parent drug and its metabolite.
Normal disposition of oxazepam in acute viral hepatitis and cirrhosis.
Unlike many other sedatives, oxazepam is eliminated normally in patients with parenchymal liver disease an therefore, on pharmacokinetic grounds, seems to be an excellent sedative for use in such persons.